Risk Factors for Cytomegalovirus Infection and Its Impact on Survival after Living Donor Liver Transplantation in South Korea: A Nested Case-Control Study

被引:6
作者
Yim, Seung Hyuk [1 ]
Choi, Mun Chae [1 ]
Kim, Deok-Gie [1 ]
Min, Eun-Ki [1 ]
Lee, Jae Geun [1 ]
Joo, Dong Jin [1 ]
Kim, Myoung Soo [1 ]
机构
[1] Yonsei Univ, Res Inst Transplantat, Dept Surg, Coll Med, Seoul 03722, South Korea
来源
PATHOGENS | 2023年 / 12卷 / 04期
关键词
liver transplantation; cytomegalovirus; living donor; RECIPIENTS; PROPHYLAXIS; DISEASE; IMMUNOSUPPRESSION; PREVENTION; MANAGEMENT; EFFICACY; STRATEGY;
D O I
10.3390/pathogens12040521
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cytomegalovirus (CMV), a common pathogen, causes infectious complications and affects long-term survival after transplantation. Studies examining living donor liver transplantation (LDLT) are limited. This study analyzed the risk factors for CMV infection and its impact on the survival of LDLT patients. A nested case-control design retrospectively analyzed data from 952 patients who underwent LDLT from 2005-2021. The incidence of CMV infection for the study cohort was 15.2% at 3 months for LDLT patients managed preemptively. Patients with CMV infections were matched with those without the infection at corresponding time points (index postoperative day) in a 1:2 ratio. Graft survival was significantly lower in the CMV infection group than in the control group. CMV infection was an independent risk factor for graft survival in the matched cohort (HR 1.93, p = 0.012). Independent risk factors for CMV infection were female sex (HR 2.4, p = 0.003), pretransplant MELD (HR 1.06, p = 0.004), pretransplant in-hospital stay (HR 1.83, p = 0.030), ABO incompatibility (HR 2.10, p = 0.009), donor macrovesicular steatosis >= 10% (HR 2.01, p = 0.030), and re-operation before index POD (HR 2.51, p = 0.035). CMV infection is an independent survival risk factor, and its risk factors should be included in the surveillance and treatment of CMV infections after LDLT.
引用
收藏
页数:9
相关论文
共 24 条
  • [1] Is Cytomegalovirus Prophylaxis Dispensable in Patients Receiving an mTOR Inhibitor-Based Immunosuppression? A Systematic Review and Meta-Analysis
    Andrassy, Joachim
    Hoffmann, Verena S.
    Rentsch, Markus
    Stangl, Manfred
    Habicht, Antje
    Meiser, Bruno
    Fischereder, Michael
    Jauch, Karl-Walter
    Guba, Markus
    [J]. TRANSPLANTATION, 2012, 94 (12) : 1208 - 1217
  • [2] Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy
    Atabani, S. F.
    Smith, C.
    Atkinson, C.
    Aldridge, R. W.
    Rodriguez-Peralvarez, M.
    Rolando, N.
    Harber, M.
    Jones, G.
    O'Riordan, A.
    Burroughs, A. K.
    Thorburn, D.
    O'Beirne, J.
    Milne, R. S. B.
    Emery, V. C.
    Griffiths, P. D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (09) : 2457 - 2464
  • [3] Role of cytomegalovirus specific cell-mediated immunity in the monitoring of cytomegalovirus infection among living donor liver transplantation adult recipients: A single-center experience
    Bhugra, Arjun
    Khodare, Arvind
    Agarwal, Reshu
    Pamecha, Viniyendra
    Gupta, Ekta
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2023, 25 (01)
  • [4] Risk factors for early viral infections after liver transplantation
    Busch, Cornelius Johannes
    Siegler, Benedikt Hermann
    Werle, Heike
    Lichtenstern, Christoph
    Bruckner, Thomas
    Heininger, Alexandra
    Mehrabi, Arianeb
    Weiss, Karl Heinz
    Weigand, Markus Alexander
    Hochreiter, Marcel
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2018, 403 (04) : 509 - 519
  • [5] Present status of ABO-incompatible living donor liver transplantation in japan
    Egawa, Hiroto
    Teramukai, Satoshi
    Haga, Hironori
    Tanabe, Mnoru
    Fukushima, Masanori
    Shirnazu, Motohide
    [J]. HEPATOLOGY, 2008, 47 (01) : 143 - 152
  • [6] A Direct and Indirect Comparison Meta-Analysis on the Efficacy of Cytomegalovirus Preventive Strategies in Solid Organ Transplant
    Florescu, Diana F.
    Qiu, Fang
    Schmidt, Cynthia M.
    Kalil, Andre C.
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 58 (06) : 785 - 803
  • [7] Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients
    Gane, E
    Saliba, F
    Valdecasas, GJC
    OGrady, J
    Pescovitz, MD
    Lyman, S
    Robinson, CA
    [J]. LANCET, 1997, 350 (9093) : 1729 - 1733
  • [8] Outcomes after liver transplantation in Korea: Incidence and risk factors from Korean transplantation registry
    Kim, Jong Man
    Kim, Deok Gie
    Kim, Jihyun
    Lee, Keunsung
    Lee, Kwang-Woong
    Ryu, Je Ho
    Kim, Bong-Wan
    Choi, Dong Lak
    You, Young Kyoung
    Kim, Dong-Sik
    Nah, Yang Won
    Kang, Koo Jeong
    Cho, Jai Young
    Hong, Geun
    Yu, Hee Chul
    Moon, Ju Ik
    Choi, Dongho
    Hwang, Shin
    Kim, Myoung Soo
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (03) : 451 - 462
  • [9] ABO-incompatible living donor liver transplantation is suitable in patients without ABO-matched donor
    Kim, Jong Man
    Kwon, Choon Hyuck David
    Joh, Jae-Won
    Kang, Eun-Suk
    Park, Jae Berm
    Lee, Joon Hyeok
    Kim, Sung Joo
    Paik, Seung Woon
    Lee, Suk-Koo
    Kim, Dae Won
    [J]. JOURNAL OF HEPATOLOGY, 2013, 59 (06) : 1215 - 1222
  • [10] Is Cytomegalovirus Infection Dangerous in Cytomegalovirus-Seropositive Recipients After Liver Transplantation?
    Kim, Jong Man
    Kim, Sung-Joo
    Joh, Jae-Won
    Kwon, Choon Hyuck David
    Song, Sanghyun
    Shin, Milljae
    Moon, Ju Ik
    Kim, Gaab Soo
    Hong, Seung Heui
    Lee, Suk-Koo
    [J]. LIVER TRANSPLANTATION, 2011, 17 (04) : 446 - 455